Trial site
Consorcio Hospitalario Provincial De Castellon
- 22running trials
- 8closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Lung cancer14 trials
- Prostate cancer7 trials
- Metastatic breast cancer5 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Brain metastases1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 316 trials
- Phase 210 trials
- Phase 2/32 trials
- Phase 42 trials
- Phase 11 trial
- Status
- Recruiting11 trials
- Active, not recruiting9 trials
- Completed8 trials
- Not yet recruiting2 trials
- Suspended1 trial
- Lead sponsor
- AstraZeneca3 trials
- MedSIR3 trials
- Aragon Pharmaceuticals, Inc.2 trials
- Astellas Pharma Global Development, Inc.2 trials
- BioNTech SE2 trials
- and 19 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Recruiting
Active, not recruiting
Recruiting
Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.
Active, not recruiting
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer7 recruiting
- Metastatic breast cancer2 recruiting
- Prostate cancer2 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026